Holen Sie sich die Stockscreener-App
44.52
7.06%
-3.24
Schlusskurs vom Vortag:
$47.76
Offen:
$47.18
24-Stunden-Volumen:
400.92K
Relative Volume:
0.25
Marktkapitalisierung:
$4.54B
Einnahmen:
$47.30M
Nettoeinkommen (Verlust:
$-225.97M
KGV:
-18.94
EPS:
-2.35
Netto-Cashflow:
$-188.86M
1W Leistung:
-1.29%
1M Leistung:
-3.27%
6M Leistung:
+11.79%
1J Leistung:
-2.22%
1-Tages-Spanne:
$44.07
$48.28
1-Wochen-Bereich:
$43.25
$48.28
52-Wochen-Spanne:
$22.71
$48.28
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Firmenname
Scholar Rock Holding Corp
Sektor
Branche
Telefon
857-259-3860
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie SRRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
44.50 | 4.87B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.19 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
817.04 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.61 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.10 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Citigroup | Buy |
| 2025-11-18 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-09 | Eingeleitet | BofA Securities | Buy |
| 2025-09-17 | Eingeleitet | Barclays | Overweight |
| 2025-09-15 | Eingeleitet | Leerink Partners | Outperform |
| 2025-08-21 | Fortgesetzt | Jefferies | Buy |
| 2025-07-30 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-07-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-11-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-10-07 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Strong Buy |
| 2023-10-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-07-12 | Eingeleitet | Truist | Buy |
| 2022-03-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-06 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-12 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Scholar Rock (NASDAQ:SRRK) Reaches New 12-Month HighHere's What Happened - MarketBeat
Marantz Jing L., chief medical officer at Scholar Rock, sells $257,881 in stock - Investing.com Canada
Scholar Rock CSO Qatanani sells $373k in shares By Investing.com - Investing.com Australia
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 6,600 Shares of Stock - MarketBeat
Caryn Parlavecchio, CHRO of Scholar Rock, sells $293k in shares - Investing.com Nigeria
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 8,406 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) General Counsel Junlin Ho Sells 8,016 Shares - MarketBeat
Scholar Rock CSO Qatanani sells $373k in shares - Investing.com
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
Can Scholar Rock Holding Corporation stock sustain revenue growthEarnings Overview Summary & Verified Momentum Stock Watchlist - bollywoodhelpline.com
Scholar Rock (NASDAQ:SRRK) Insider Mo Qatanani Sells 13,112 Shares of Stock - MarketBeat
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock By Investing.com - Investing.com Nigeria
Two new Scholar Rock hires receive 35,200-share equity grant package - Stock Titan
Scholar Rock Holding Insider Sold Shares Worth $2,453,115, According to a Recent SEC Filing - marketscreener.com
Vaishnaw, Scholar Rock president, sells $872k in shares By Investing.com - Investing.com Nigeria
Hallal, CEO of Scholar Rock, sells $2.45 million in SRRK stock - Investing.com Australia
Insider Selling: Scholar Rock (NASDAQ:SRRK) COO Sells 16,746 Shares of Stock - MarketBeat
Insider Selling: Scholar Rock (NASDAQ:SRRK) Insider Sells 20,438 Shares of Stock - MarketBeat
Scholar Rock (NASDAQ:SRRK) CFO Vikas Sinha Sells 16,755 Shares - MarketBeat
Scholar Rock (SRRK) COO Woods sells $715k in stock By Investing.com - Investing.com Nigeria
Scholar Rock CFO Sinha sells $715k in shares By Investing.com - Investing.com Canada
Vaishnaw, Scholar Rock president, sells $872k in shares - Investing.com
Scholar Rock (SRRK) COO Woods sells $715k in stock - Investing.com
Scholar Rock CFO Sinha sells $715k in shares - Investing.com
Scholar Rock Executives Sell Shares to Cover Tax Obligations - TradingView — Track All Markets
SRRK: Barclays Maintains 'Overweight' Rating, Lowers Price Targe - GuruFocus
SRRK: Analyst Maintains Rating but Lowers Price Target to $44 | - GuruFocus
Insider Trends: Will Scholar Rock Holding Corporation stock gain from lower inflationDay Trade & Free Accurate Trade Setup Notifications - Bộ Nội Vụ
BMO Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $50 - 富途资讯
New muscle-targeting SMA drug could reach children and adults in 2026 - Stock Titan
Scholar Rock Highlights 2026 Strategic Priorities - Yahoo Finance
Peregrine Capital Management LLC Makes New $5.77 Million Investment in Scholar Rock Holding Corporation $SRRK - MarketBeat
SRRK Receives New 'Buy' Rating from Citigroup with $55 Price Tar - GuruFocus
StoneCrest Wealth Management Inc. Takes Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock (NASDAQ:SRRK) Upgraded at UBS Group - MarketBeat
Scholar Rock (NASDAQ:SRRK) Clinical Biologics In Nasdaq Composite - Kalkine Media
Is Scholar Rock Holding Corporation stock attractive after correctionWeekly Stock Report & Low Drawdown Trading Strategies - Улправда
SRRK: UBS Initiates Coverage with a 'Buy' Rating and $60 Price T - GuruFocus
UBS initiates Scholar Rock stock with Buy rating, sets $60 price target - Investing.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with a Promising 12% Upside - DirectorsTalk Interviews
Scholar Rock jumps following Regeneron Eylea update - MSN
Scholar Rock: Apitegromab's Path Forward Remains Intact, Maintaining Buy Rating - Seeking Alpha
Biotech focused on rare muscle diseases joins J.P. Morgan health conf - Stock Titan
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Scholar Rock Holding Corporation $SRRK Shares Acquired by Moody Aldrich Partners LLC - MarketBeat
SRRK stock drops 3% today: What’s driving Scholar Rock shares as FDA reinspection nears - ts2.tech
Scholar Rock's chief commercial officer sells $171,927 in common stock - MSN
Scholar Rock Holding Corporation $SRRK Shares Bought by Voya Investment Management LLC - MarketBeat
Can Scholar Rock Holding Corporation stock weather global recessionGap Down & Expert Approved Momentum Trade Ideas - Улправда
Why Scholar Rock Holding Corporation (2QK) stock is listed among top recommendationsJuly 2025 Earnings & Fast Moving Trade Plans - DonanımHaber
Finanzdaten der Scholar Rock Holding Corp-Aktie (SRRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.31%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):